Ai-Robotics

Beijing Ai-Robotics Technology Co., Ltd. developed China’s first NMPA-certified lower-limb exoskeleton robot in 2018, establishing itself as a pioneer in the domestic rehabilitation robotics sector. Founded by Professor Shuai Mei from Beihang University, the company has deployed its exoskeleton systems across more than 300 hospitals nationwide and provided rehabilitation training to over one million patients.

Company Overview

Ai-Robotics emerged from over a decade of academic research at Beihang University, where Professor Shuai Mei began developing exoskeleton technology around 2010 with the goal of creating a therapeutic device for patients with lower limb dysfunction. The company was formally established in April 2016 and relocated to Beijing’s Yizhuang Economic Development Zone in 2017.

The company achieved a breakthrough in 2017 when its exoskeleton rehabilitation robot became the first Class II innovative medical device approved under China’s “green channel” expedited review policy. In June 2018, Ai-Robotics received NMPA registration certificates for its AiKang and AiDong products, making them the first domestically developed lower-limb exoskeleton robots to receive regulatory approval in China.

Professor Shuai Mei serves as founder and chairman, bringing expertise in robotics and rehabilitation engineering. The company has participated in multiple national research programs including the “12th Five-Year” Science and Technology Support Plan and National Natural Science Foundation projects.

Core Products

Ai-Robotics has developed seven product series with over ten exoskeleton robot models, spanning medical rehabilitation to consumer applications:

Medical Rehabilitation Series

AiDong Series (“Treatment King”): Frame-mounted exoskeleton weighing approximately 80kg, designed for early-stage rehabilitation patients. Addresses high muscle tone and muscle contracture issues in patients with prolonged bed rest due to paraplegia. Enables suspended and real ground walking exercises.

AiKang Series (“All-Round King”): Portable exoskeleton requiring elbow crutches for balance. Provides scientific gait rehabilitation training to improve joint function and muscle strength. Suitable for mid-to-late stage recovery.

AiWalk Series (“Smart King”): AI-powered exoskeleton with intelligent, precise assistance. Features real-time motion intent detection and automatic force adjustment based on patient recovery progress.

Consumer and Home Series

AiJia Series: Home rehabilitation version with reduced price point (under 100,000 RMB compared to previous products approaching one million RMB). Enables patients to continue rehabilitation training outside clinical settings.

ShenXing Series: Consumer-grade exoskeleton at the thousand-RMB level, designed for elderly users and outdoor enthusiasts to reduce fatigue and protect joints during walking.

Technology & Innovation

With products deployed in over 300 hospitals and more than one million patient sessions logged, Ai-Robotics leads China’s lower-limb exoskeleton rehabilitation market.

Ai-Robotics’ exoskeleton systems incorporate several technical features:

• AI-based motion detection: Real-time capture of patient movement intent through sensor arrays
• Multi-joint actuation: Precise assistance at hip, knee, and ankle joints to simulate natural gait patterns
• Adaptive training modes: Passive mode for full walking assistance, power-assisted mode for partial support, and active mode encouraging patient participation
• Digital twin technology: Personalized training protocols based on individual recovery data

The company holds multiple patents and has participated in national key R&D programs. Products are developed under the “12th Five-Year” Science and Technology Support Plan and Beijing Major Science and Technology Plan initiatives.

Market Presence

For stroke, paraplegia, and other lower-limb dysfunction patients, Ai-Robotics builds exoskeleton systems deployed across more than 300 hospitals and covered by Beijing and Shaanxi medical insurance.

Ai-Robotics has established significant market penetration in China’s rehabilitation sector:

• Over 300 hospitals using Ai-Robotics exoskeleton systems
• Cumulative training exceeding one million patient sessions
• Partnerships with major medical institutions including PLA General Hospital (301 Hospital), Beijing Jishuitan Hospital, Beijing Xuanwu Hospital, Jiangsu Provincial People’s Hospital, and Wuhan Tongji Hospital
• Product pricing ranges from thousands to hundreds of thousands of RMB, with some models included in Beijing and Shaanxi provincial medical insurance coverage

The company has expanded beyond clinical settings to serve rehabilitation centers, community healthcare facilities, and individual home users.

Key Milestones

• 2013: Professor Shuai Mei’s team at Beihang University develops China’s first exoskeleton robot prototype
• 2016: Beijing Ai-Robotics Technology Co., Ltd. formally established
• 2017: Product designated as Beijing’s first Class II innovative medical device and China’s first under expedited review policy; Won second place at Pitch@Palace global competition
• 2018: AiKang and AiDong receive NMPA registration certificates as China’s first approved lower-limb exoskeletons; Completed Pre-A funding round led by Jinke Junchuang Capital; Paraplegic patient completed full marathon wearing Ai-Robotics exoskeleton (world record)
• 2022: Selected as official exoskeleton provider for Beijing Winter Paralympics torch relay; Paraplegic torch bearers completed relay wearing Ai-Robotics devices
• 2025: Launched consumer-grade ShenXing series; Participated in Beijing Intelligent Elderly Care Robot Application Competition

Frequently Asked Questions

What conditions can Ai-Robotics exoskeletons treat?

Ai-Robotics exoskeletons are designed for patients with lower limb motor dysfunction, including those with spinal cord injuries (paraplegia), stroke (hemiplegia), cerebral palsy, progressive muscle weakness, Parkinson’s disease, and age-related lower limb degeneration. The devices help rebuild neural function and correct abnormal gait patterns.

Is Ai-Robotics publicly traded?

No, Ai-Robotics remains a privately held company. The company completed a Pre-A funding round in February 2018 led by Jinke Junchuang Capital with participation from Silicone Valley Paradise Asset Management Group.

How does Ai-Robotics compare to international exoskeleton companies?

Ai-Robotics was the first Chinese company to receive NMPA certification for lower-limb exoskeletons (2018), positioning it as a domestic pioneer. The company participated in the 2017 Pitch@Palace competition alongside global competitors including ReWalk Robotics (Israel), Cyberdyne (Japan), and Ekso Bionics (US), winning second place. Unlike some international products focused solely on mobility assistance, Ai-Robotics emphasizes therapeutic rehabilitation with the goal of enabling patients to eventually walk without the device.